share_log

平安好醫生:2024中期報告

PA GOODDOCTOR: 2024 Interim Report

HKEX ·  Aug 28 16:31

Summary by Futu AI

平安健康科技有限公司(平安好醫生)於2024年發佈中期報告,顯示公司秉持「省心、省時、又省錢」的價值主張,透過完善的供應商網絡、領先的服務體系等核心競爭優勢,深化管理式醫療模式的探索與實踐。報告期內,公司持續深化醫療戰略,實現運營效率和服務質量的提升,並整體實現扭虧為盈。中期報告顯示,2024年上半年公司錄得總收入2,093.4百萬元人民幣,較2023年同比下降5.8%,毛利673.8百萬元,淨利潤60.6百萬元人民幣。報告期內,平安健康推出全面升級的家庭醫生服務品牌「平安家醫」,並與平安集團深度協同,持續打造中國版管理式醫療模式。公司股份代號為1833.HK,中期報告已於公司網站及披露易網站上登載。
平安健康科技有限公司(平安好醫生)於2024年發佈中期報告,顯示公司秉持「省心、省時、又省錢」的價值主張,透過完善的供應商網絡、領先的服務體系等核心競爭優勢,深化管理式醫療模式的探索與實踐。報告期內,公司持續深化醫療戰略,實現運營效率和服務質量的提升,並整體實現扭虧為盈。中期報告顯示,2024年上半年公司錄得總收入2,093.4百萬元人民幣,較2023年同比下降5.8%,毛利673.8百萬元,淨利潤60.6百萬元人民幣。報告期內,平安健康推出全面升級的家庭醫生服務品牌「平安家醫」,並與平安集團深度協同,持續打造中國版管理式醫療模式。公司股份代號為1833.HK,中期報告已於公司網站及披露易網站上登載。
Ping An Health Technology Co., Ltd. (Good Doctor) released its mid-term report in 2024, showing that the company upholds the value proposition of "convenience, time-saving, and cost-saving", and explores and practices the management-based healthcare model through a complete supplier network and leading service system. During the reporting period, the company continued to deepen its medical strategy, improve operational efficiency and service quality, and achieved an overall turnaround. The mid-term report showed that the company recorded a total revenue of 2,093.4 million RMB in the first half of 2024, a decrease of 5.8% compared to the same period in 2023, with gross profit of 673.8 million RMB and net profit of 60.6 million RMB. During the reporting period, Ping An Health launched the...Show More
Ping An Health Technology Co., Ltd. (Good Doctor) released its mid-term report in 2024, showing that the company upholds the value proposition of "convenience, time-saving, and cost-saving", and explores and practices the management-based healthcare model through a complete supplier network and leading service system. During the reporting period, the company continued to deepen its medical strategy, improve operational efficiency and service quality, and achieved an overall turnaround. The mid-term report showed that the company recorded a total revenue of 2,093.4 million RMB in the first half of 2024, a decrease of 5.8% compared to the same period in 2023, with gross profit of 673.8 million RMB and net profit of 60.6 million RMB. During the reporting period, Ping An Health launched the upgraded family doctor service brand "Ping An Family Doctor", and cooperated deeply with Ping An Group to continuously build the Chinese version of the management-based healthcare model. The company's stock code is 1833.HK, and the mid-term report has been posted on the company's website and the disclosure website.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.